UBS launches loan product
UBS has launched a new product – a limited recourse loan with no margin calls.
The company launched the product, UBS Investment Builders, this week claiming it would investors the ability to purchase shares, exchange traded funds (ETFs) and listed managed funds by paying a portion of the underlying security price themselves, while UBS then provided a limited recourse loan for the balance of the purchase price.
It said a key feature of buying the underlying shares through UBS Investment Builders was that investors became the beneficial owner and received exposure to price performance, dividends and potential franking credits.
The company claimed superannuation funds would be able to use UBS Investment Builders as one of the few ways to borrow to invest in listed shares and ETFs.
Commenting on the product, UBS head of derivative sales, Travis Miller said the product was innovative because it combined a limited recourse loan with a share or ETF that could be purchased on the ASX in a similar way to buying shares outright.
"UBS Investment Builders also offer individuals and SMSFs the benefits of potential interest deductions and franking credits, and in the case of UBS Dividend Builders, access to potentially enhanced dividend income streams,” he said.
Recommended for you
With an advice M&A deal taking around six months to enact, two experts have shared their tips on how buyers and sellers can avoid “deal fatigue” and prevent potential deals from collapsing.
Several financial advisers have been shortlisted in the ninth annual Women in Finance Awards 2025, to be held on 14 November.
Digital advice tools are on the rise, but licensees will need to ensure they still meet adviser obligations or potentially risk a class action if clients lose money from a rogue algorithm.
Shaw and Partners has merged with Sydney wealth manager Kennedy Partners Wealth, while Ord Minnett has hired a private wealth adviser from Morgan Stanley.
